RoC Deep Wrinkle Rich Cream: retinol claims beside the estrogen story

The product record names RETINOL CORREXION Deep Wrinkle Rich Cream and lists 1.7 fl oz, or 50 mL. RoC’s ingredient-question page separately shows the same named cream at $34.99. That is a manufacturer display, without a completed purchase or confirmation of current stock.

The exact item matters because RoC’s educational material names several other retinol products. Their concentrations, textures and results cannot be substituted for this cream’s details. The current Deep Wrinkle Rich Cream can be assessed through the records that identify that name, its 1.7 fl oz amount and its own declared formula.

The posted ingredients include retinol, Ceramide AP, NP and EOP, glycerin and sodium hyaluronate. The manufacturer’s declaration also marks a component with a footnote describing it as a calcium apatite derivative. This provides a concrete formula reference alongside the broader bio-ceramide and calcium wording.

The list does not give a retinol percentage. RoC’s FAQ says it does not publish exact ingredient percentages for every product and emphasizes proprietary blends and delivery systems. That explanation supplies the company’s reason for its approach, not the missing numerical concentration for this cream. Neither the strength nor a concentration match with another RoC item can be inferred from a familiar ingredient name.

RoC’s product description links persistent dryness, firmness loss and deeper-looking wrinkles with estrogen decline. It then describes retinol, ceramides and calcium as part of its appearance-care response. That marketing account does not establish that the cream contains estriol or produces the effects of a prescribed hormone preparation.

AAD’s menopause discussion separately recognizes that skin can become drier as its ability to hold water changes. This provides context for the concern, without validating RoC’s current cream. The estriol identity guide explains the distinct hormone question. A person’s medical situation cannot be determined from the cream’s estrogen-loss wording, and a retail appearance benefit should not be treated as evidence of treatment equivalence.

The product FAQ associates its 100-hour hydration claim with a self-assessment study involving 32 volunteers. That is more specific than a bare hydration headline: it identifies the type of assessment and a participant count. It does not supply the complete protocol, comparison group or distribution of individual responses.

The number should remain attached to the hydration statement, rather than being borrowed as the population for every result on the page. No full underlying report was acquired. A self-assessment also is not automatically an instrumental measurement of retained water. The hydration-versus-firmness discussion helps distinguish that moisturized-skin question from the cream’s separate promises about firmness and the appearance of deep wrinkles.

RoC’s results section reports improved firmness for 96% at one week and visibly reduced deep-wrinkle appearance for 100% at 12 weeks. The page links the later wrinkle results to instrumentation over a 12-week clinical study. It also uses a skin-age appearance comparison of up to ten years.

Those statements do not provide the participant denominator or a complete explanation of the measurements. They should not be combined with the 32-volunteer hydration footnote unless a report establishes that connection. The skin-age phrase describes a brand appearance claim, not a reversal of someone’s chronological age. Without the full methods, the percentages remain attributed summaries whose population, comparison and clinical significance cannot be independently evaluated from the returned page.

The product footnotes describe the seven-times retinol statement in terms of an ingredient study, including a comparison at an equal concentration of traditional retinol. That is a different subject from a head-to-head trial of this cream against seven other products. It supplies no retinol percentage for the current jar.

The brand FAQ also treats sensitivity as dependent on the person and specific preparation. AAD’s menopause context recognizes increased dryness and irritation concerns. These boundaries matter beside a powerful-sounding ingredient claim: neither a multiplier nor fragrance-free positioning settles an individual tolerance question. This review does not turn the manufacturer’s educational instructions into a personal regimen or a guarantee that the cream will be comfortable.

Deep Wrinkle Rich Cream has a named declaration, a stated amount and several distinct result summaries. The product evidence is most useful when hydration, firmness, wrinkle appearance and the ingredient multiplier are kept apart. A full report would clarify the populations and tests supporting each outcome.

For further reading, the L’Oréal cream review and Neutrogena cream review consider separate manufacturer records. The broader comparison adds category context. Those destinations do not establish a winner or comparable study results. The appropriate comparison starts with the benefit a reader wants explained and asks whether the exact preparation’s evidence actually assessed it.